Citadel Advisors’s Vivani Medical VANI Stock Holding History
Bought
Maintained
Sold
Other funds holding VANI
VCM
TWM
VFT
MMG
Citadel Advisors's VANI Position: Q1 2026 in Review
Citadel Advisors sold out of Vivani Medical (VANI) in Q1 2026, closing a stake of 40,409 shares — an estimated $50.5K sold.
Citadel Advisors first reported a position in VANI in Q1 2015 and held it in 19 quarters. The position peaked at $440K in Q2 2021. 43 funds tracked by Wall St. Rank hold VANI as of Q1 2026.
- Citadel Advisors reported no remaining Vivani Medical position as of Q1 2026 after selling out during the quarter.
- Citadel Advisors sold 40,409 Vivani Medical shares in Q1 2026, an estimated $50.5K.
- Citadel Advisors first reported a position in Vivani Medical in Q1 2015 and held it in 19 quarters.
- Citadel Advisors's Vivani Medical position peaked at $440K in Q2 2021.
- 43 funds tracked by Wall St. Rank held Vivani Medical as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.